Both in Pharmaceuticals
Avalo Therapeutics vs Assembly Biosciences
Over the past year AVTX returned −56.1% and ASMB returned −37.4%; their daily moves had a correlation of 0.32.
AVTX −56.1% ASMB −37.4%Growth of $1, one year, split-adjusted
| Metric | AVTX | ASMB |
|---|---|---|
| Price | $7.32 | $19.51 |
| Market cap | $392.6M | $397.2M |
| Today | +2.09% | −3.08% |
| 1 month | −51.2% | −13.4% |
| 6 months | −46.9% | −29.9% |
| Year to date | −59.7% | −42.6% |
| 1 year | −59.4% | −35.2% |
| Revenue growth (YoY) | — | +38.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −28.8% |
| P/E (TTM) | — | — |
| Price / sales | 6,653.8× | 5.3× |
| Net cash | $400.3M | $320.4M |
| Dividend yield | — | — |
| Volatility (60d) | 115.1% | 63.6% |
| Short % of float | 24.6% | 28.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).